| Title |
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
|
|---|---|
| Published in |
Cancer Cell International, September 2019
|
| DOI | 10.1186/s12935-019-0949-0 |
| Pubmed ID | |
| Authors |
Yong Le, Anna Kan, Qi-Jiong Li, Min-Ke He, Hai-Long Chen, Ming Shi |
Mendeley readers
The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 7 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 2 | 29% |
| Student > Bachelor | 1 | 14% |
| Lecturer | 1 | 14% |
| Researcher | 1 | 14% |
| Professor > Associate Professor | 1 | 14% |
| Other | 0 | 0% |
| Unknown | 1 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 2 | 29% |
| Nursing and Health Professions | 1 | 14% |
| Biochemistry, Genetics and Molecular Biology | 1 | 14% |
| Agricultural and Biological Sciences | 1 | 14% |
| Materials Science | 1 | 14% |
| Other | 0 | 0% |
| Unknown | 1 | 14% |